International Journal of Clinical Oncology

, Volume 19, Issue 5, pp 805–813 | Cite as

Changing patterns in thyroid cancer incidence and mortality in the Slovak Republic by histological type and age

Original Article

Abstract

Background

Thyroid cancer (TC) is the most common malignant disease of the endocrine system; however, in the Slovak Republic (SR), time trends of incidence and mortality according to histological type and age of patients have never been reported.

Materials and methods

Long-term (1968–2007) trends from the National Cancer Registry data of overall, histology and age-specific incidence and mortality in the SR have been calculated using join-point regression and other descriptive characteristics.

Results

Age-standardized overall incidence rates increased significantly in females by an estimated annual percentage change (APC) of 3.6 %, and in males by 2.2 %. Overall mortality decreased by APC −2.1 % in females and −0.9 % in males. The mean ages of female and male TC patients at the time of diagnosis significantly decreased; ages at the time of death significantly increased. The incidence of papillary carcinoma rose significantly in females by 8.9 %, compared with 6.1 % in males; follicular carcinoma in males and females was stable. Medullary carcinoma was stable in females; in males, it rose by 5.2 %. Poorly differentiated TC was stable in females; undifferentiated/anaplastic carcinomas decreased in both sexes.

Conclusions

The incidence of TC, especially of selected histological types, is dramatically rising in the SR in both genders, while mortality is decreasing. Patients diagnosed in recent years are younger and died at a greater age than those reported in older national data. These trends seem to be affected by more intensive diagnosis in the most recent years.

Keywords

Thyroid cancer: incidence Mortality Prevalence Histological types 

Notes

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Steliarova-Foucher E, O’Callaghan M, Ferlay J et al (2012) European cancer observatory: cancer incidence, mortality, prevalence and survival in Europe. Version 1.0. European Network of Cancer Registries. IARC, LyonGoogle Scholar
  2. 2.
    Aschebrook-Kilfoy B, Ward MH, Sabra MM et al (2011) Thyroid cancer incidence patterns in the United States by histologic type, 1992–2006. Thyroid 21:125–134PubMedCrossRefPubMedCentralGoogle Scholar
  3. 3.
    How J, Tabah R (2007) Explaining the increasing incidence of differentiated thyroid cancer. CMAJ 177:1383–1384PubMedCrossRefPubMedCentralGoogle Scholar
  4. 4.
    Ondrusova M, Plesko I, Safaei-Diba Ch et al (2007) Comprehensive analysis of incidence and mortality of malignant tumours in the Slovak Republic (online). National Cancer Registry of the Slovak Republic, NHIC Bratislava. http://www.nor-sk.org/. Accessed Apr 2009
  5. 5.
    Schneider DF, Chen H (2013) New developments in the diagnosis and treatment of thyroid cancer. CA Cancer J Clin. doi: 10.3322/caac.21195
  6. 6.
    Safaei-Diba Ch, Plesko I (eds) (2008) Cancer incidence in the Slovak Republic 2004. NCR SR, NHIC BratislavaGoogle Scholar
  7. 7.
    Safaei-Diba Ch, Plesko I, Obsitnikova A (eds) (2009) Cancer incidence in the Slovak Republic 2005. NCR SR, NHIC BratislavaGoogle Scholar
  8. 8.
    Safaei-Diba Ch, Plesko I, Hlava P (eds) (2010) Cancer incidence in the Slovak Republic 2006. NCR SR, NHIC BratislavaGoogle Scholar
  9. 9.
    Safaei-Diba Ch, Plesko I, Hlava P (eds) (2012) Cancer incidence in the Slovak Republic 2007. NCR SR, NHIC BratislavaGoogle Scholar
  10. 10.
    Vanuga P, Pura M, Plesko I et al (2007) Incidence of thyroid cancer in Slovakia: extensive evidence from one centre in the context of national data. Cas Lek Ces 146:148–152Google Scholar
  11. 11.
    Bray F, Guilloux A, Sankila R et al (2002) Practical implications of imposing a new world standard population. Cancer Causes Control 13:175–182PubMedCrossRefGoogle Scholar
  12. 12.
    Kim HJ, Fay MP, Feuer EJ et al (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 16:335–351CrossRefGoogle Scholar
  13. 13.
    Steliarova-Foucher E, Stiller CA, Pukkala E et al (2006) Thyroid cancer incidence and survival among European children and adolescents (1978–1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer 42:2150–2169PubMedCrossRefGoogle Scholar
  14. 14.
    DeLellis RA, Lloyd RV, Heitz PU et al (2004) Pathology and genetics of tumours of endocrine organs. WHO Classification of tumours. IARC Press, LyonGoogle Scholar
  15. 15.
    Ferlay J, Shin HR, Bray F et al (2010) GLOBOCAN 2008, cancer incidence and mortality worldwide: IARC CancerBase No. 10. IARC, LyonGoogle Scholar
  16. 16.
    Pellegriti G, Frasca F, Regalbuto C et al (2013) Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol 2013:965212PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    Lukas J, Drabek J, Lukas D et al (2013) The epidemiology of thyroid cancer in the Czech Republic in comparison with other countries. Biomed Pap Med Fac Univ Palacky Olomouc Czech Republic 157:266–275Google Scholar
  18. 18.
    Colonna M, Guizard AV, Schvartz C et al (2007) A time trend analysis of papillary and follicular cancers as a function of tumour size: a study of data from six cancer registries in France (1983–2000). Eur J Cancer 43:891–900PubMedCrossRefGoogle Scholar
  19. 19.
    Wartofsky L (2010) Increasing world incidence of thyroid cancer: increased detection or higher radiation exposure? Hormones 9:103–108PubMedCrossRefGoogle Scholar
  20. 20.
    Mahoney MC, Lawvere S, Falkner KL et al (2004) Thyroid cancer incidence trends in Belarus: examining the impact of Chernobyl. Int J Epidemiol 33:1025–1033PubMedCrossRefGoogle Scholar
  21. 21.
    Reynolds RM, Weir J, Stockton DL et al (2005) Changing trends in incidence and mortality of thyroid cancer in Scotland. Clin Endocrinol 62:156–162CrossRefGoogle Scholar
  22. 22.
    Colonna M, Bossard N, Guizard A et al (2010) Descriptive epidemiology of thyroid cancer in France: incidence, mortality and survival. Ann Endocrinol 71:95–101CrossRefGoogle Scholar
  23. 23.
    Enewold L, Zhu K, Ron E et al (2009) Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980–2005. Cancer Epidemiol Biomarkers Prev 18:784–791PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    Kilfoy BA, Zheng T, Holford TR et al (2009) International patterns and trends in thyroid cancer incidence, 1973−2002. Cancer Causes Control 20:525–531PubMedCrossRefPubMedCentralGoogle Scholar
  25. 25.
    Podoba J (2005) The most frequent thyropathies in general practitioner’s office. Via Pract 2:230–235Google Scholar
  26. 26.
    Podoba J (1995) Ultrasound examination of thyroid and parathyroid glands. In: Kovac A (ed) Abdominal ultrasound. Osveta, Bratislava, pp 345–358Google Scholar
  27. 27.
    Hussson O, Haak HR, van Steenbergen LN et al (2013) Rising incidence, no change in survival and decreasing mortality from thyroid cancer in The Netherlands since 1989. Endrocr Relat Cancer 20:263–271CrossRefGoogle Scholar
  28. 28.
    Langer P (1980) Eastern and southeastern Europe. In: Stanbury JB, Heitzel BS (eds) Endemic goiter and endemic cretinism iodine nutrition in health and disease. Wiley Medical, New York, pp 141–153Google Scholar

Copyright information

© Japan Society of Clinical Oncology 2013

Authors and Affiliations

  • Martina Ondrusova
    • 1
    • 2
  • Karol Kajo
    • 3
  • Dalibor Ondrus
    • 4
  1. 1.St. Elisabeth University of Health and Social SciencesBratislavaSlovak Republic
  2. 2.Cancer Research InstituteSlovak Academy of SciencesBratislavaSlovak Republic
  3. 3.Department of Pathology, St. Elisabeth Cancer InstituteSlovak Medical UniversityBratislavaSlovak Republic
  4. 4.1st Department of Oncology, St. Elisabeth Cancer InstituteComenius University School of MedicineBratislavaSlovak Republic

Personalised recommendations